Sonolisib
In Stock•Starting at $481 for 1 mg•Purity ≥ 99%
| CAS No. | 502632-66-8 |
|---|---|
| MDL No. | N/A |
| MF | C29H35NO8 |
| MW | 525.60 |
| InChI Key | QIUASFSNWYMDFS-NILGECQDSA-N |
| CAS No. | 502632-66-8 |
|---|---|
| MDL No. | N/A |
| MF | C29H35NO8 |
| MW | 525.60 |
| InChI Key | QIUASFSNWYMDFS-NILGECQDSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99% | $481 | In Stock | |
| 5 mg | 99% | $1047 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
PX-866 is an organic heterotetracyclic compound derived from wortmanin through aminolysis of its furan ring by diallyl amine. It functions as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and is classified as a delta-lactone, acetate ester, and tertiary amino compound. It is functionally related to wortmannin.
| CAS No. | 502632-66-8 |
|---|---|
| Product Name | Sonolisib |